SinoMab BioScience Limited (3681.HK) HKSE

2.29

-0.07(-2.97%)

Updated at September 08 03:42PM

Currency In HKD

Valuation

Market Cap1.1B
Enterprise Value1.52B
P/E Ratio-12.22
PEG Ratio-1.16
Price/Sales Ratio1,248.68
Price/Book Ratio11.73
Enterprise/Revenue1,456.17
Enterprise/EBITDA-20.66

Fiscal Year

Fiscal YearDecember 31, 2024
Most Recent QuarterDecember 31, 2024

Profitability

Profit Margin-91.38
Operating Margin-79.92

Management Effectiveness

Return On Assets-0.25
Return On Equity-0.79

Income Statement

Revenue2.03M
Revenue/Share0
Gross Profit543,000
EBITDA-142.79M
Net Income-185.14M
Diluted EPS-0.17

Balance Sheet

Total Cash106.88M
Total Cash/Share0.1
Total Debt482.27M
Total Debt/Equity2.5
Current Ratio0.91
Book Value Per Share0.18

Price History

52-Week Change88.52
52-Week High3.76
52-Week Low0.8
Moving Average 50 Days2.68
Moving Average 200 Days1.64

Statistics

Average Volume24.02M
Shares Outstanding1.2B
% Held by InstitutionsN/A

Dividend And Splits

Trailing Annual Dividend Rate0
Trailing Annual Dividend Yield0
Payout Ratio0
Last Split FactorN/A
Last Split DateN/A